[go: up one dir, main page]

MX2014003050A - Extractos de cynara scolymus para el tratamiento de la dislipidemia. - Google Patents

Extractos de cynara scolymus para el tratamiento de la dislipidemia.

Info

Publication number
MX2014003050A
MX2014003050A MX2014003050A MX2014003050A MX2014003050A MX 2014003050 A MX2014003050 A MX 2014003050A MX 2014003050 A MX2014003050 A MX 2014003050A MX 2014003050 A MX2014003050 A MX 2014003050A MX 2014003050 A MX2014003050 A MX 2014003050A
Authority
MX
Mexico
Prior art keywords
treatment
extracts
cynara scolymus
dyslipidaemia
patients
Prior art date
Application number
MX2014003050A
Other languages
English (en)
Other versions
MX349587B (es
Inventor
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44907959&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014003050(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Indena Spa filed Critical Indena Spa
Publication of MX2014003050A publication Critical patent/MX2014003050A/es
Publication of MX349587B publication Critical patent/MX349587B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

La presente invención se refiere a la preparación de los extractos de las hojas de Cynara scolymus, que resultan útiles para la prevención y el tratamiento de la dislipidemia, en particular para aumentar el colesterol HDL en pacientes con riesgo cardiovascular; dichos extractos son útiles para normalizar el equilibrio de lípidos y carbohidratos y aumentar significativamente el valor del colesterol HDL mediante el cambio favorable de la proporción LDL/HDL, en especial en pacientes con dislipidemia inducida por medicamentos que sufrieron un infarto.
MX2014003050A 2011-09-16 2012-09-13 Extractos de cynara scolymus para el tratamiento de la dislipidemia. MX349587B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001670A ITMI20111670A1 (it) 2011-09-16 2011-09-16 Estratti di cynara scolimus per il trattamento di dislipidemie
PCT/EP2012/067889 WO2013037857A1 (en) 2011-09-16 2012-09-13 Cynara scolymus extracts for the treatment of dyslipidaemia

Publications (2)

Publication Number Publication Date
MX2014003050A true MX2014003050A (es) 2014-04-10
MX349587B MX349587B (es) 2017-08-03

Family

ID=44907959

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003050A MX349587B (es) 2011-09-16 2012-09-13 Extractos de cynara scolymus para el tratamiento de la dislipidemia.

Country Status (22)

Country Link
US (1) US9687468B2 (es)
EP (1) EP2755669B1 (es)
JP (2) JP2014526486A (es)
KR (1) KR102026993B1 (es)
CN (2) CN111184754A (es)
AR (1) AR087878A1 (es)
AU (1) AU2012307404B2 (es)
BR (1) BR112014004532B1 (es)
CA (1) CA2845708C (es)
CL (1) CL2014000595A1 (es)
ES (1) ES2629186T3 (es)
HK (1) HK1198935A1 (es)
HU (1) HUE035035T2 (es)
IL (1) IL231497B (es)
IT (1) ITMI20111670A1 (es)
MX (1) MX349587B (es)
PL (1) PL2755669T3 (es)
PT (1) PT2755669T (es)
RU (1) RU2608459C2 (es)
SG (1) SG11201400618XA (es)
SI (1) SI2755669T1 (es)
WO (1) WO2013037857A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121570A1 (it) * 2012-09-20 2014-03-21 Indena Spa Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica
FR3042413B1 (fr) * 2015-10-20 2019-07-12 Valbiotis Composition comprenant un melange de molecules extraites de chrysanthellum indicum et de cynara scolymus et utilisation pour agir sur le metabolisme glucidique et/ou lipidique
CN108142881A (zh) * 2018-03-20 2018-06-12 爱可道生物科技有限公司 一种洋蓟花蕾提取物降血压胶囊制品及其生产工艺
WO2021220050A1 (en) * 2020-05-01 2021-11-04 Health And Happiness (H&H) Hong Kong Limited New compositions useful for treating elevated blood lipid levels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19627376A1 (de) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
EP0958828A1 (de) * 1998-05-22 1999-11-24 Greither, Peter Präparat auf der Basis der Artischockenpflanze, insbesondere zur Verwendung als Arzneimittel oder Nahrungsergänzungsmittel
US6162438A (en) * 1999-06-24 2000-12-19 Chromak Research, Inc. Herbal compositions and their use as agents for control of hypertension, hypercholesterolemia and hyperlipidemia
DE10138929A1 (de) * 2001-08-08 2003-02-27 Lichtwer Pharma Ag Artischockenblätterextrakte
CN100496525C (zh) * 2004-04-02 2009-06-10 李嫦梅 从洋蓟根、茎、叶中提取活性成份的方法及其应用
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
KR20090118050A (ko) * 2007-03-07 2009-11-17 인데나 에스.피.에이 시나라 스콜리무스 추출물 및 그를 포함하는 조성물
US20080220096A1 (en) * 2007-03-07 2008-09-11 Indena S. P. A. Cynara scolymus extracts and compositions containing them
EP1967199A1 (en) * 2007-03-07 2008-09-10 Indena S.P.A. Cynara scolymus extracts and compositions containing them
WO2009100970A1 (de) * 2008-02-14 2009-08-20 Swiss Caps Rechte Und Lizenzen Ag Darreichungsform enthaltend zubereitungen aus solanum melongena und cynara scolymus
MX2011007686A (es) * 2009-01-20 2011-08-12 Indena Spa Composiciones que comprenden un extracto lipofilo de zingiber officinale y un extracto de cynara scolymus, que son utiles para la prevencion y tratamiento de reflujo esofagico y sindrome del intestino irritable.
EP2345646A1 (en) * 2010-01-14 2011-07-20 InterMed Discovery GmbH Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions

Also Published As

Publication number Publication date
HK1198935A1 (en) 2015-06-19
IL231497A0 (en) 2014-04-30
PL2755669T3 (pl) 2017-09-29
AU2012307404B2 (en) 2017-05-25
US9687468B2 (en) 2017-06-27
EP2755669A1 (en) 2014-07-23
CL2014000595A1 (es) 2014-11-14
HUE035035T2 (en) 2018-05-02
MX349587B (es) 2017-08-03
BR112014004532A2 (pt) 2017-03-28
RU2608459C2 (ru) 2017-01-18
KR20140067044A (ko) 2014-06-03
KR102026993B1 (ko) 2019-09-30
PT2755669T (pt) 2017-06-30
ITMI20111670A1 (it) 2013-03-17
EP2755669B1 (en) 2017-04-05
JP2014526486A (ja) 2014-10-06
RU2014109450A (ru) 2015-10-27
BR112014004532B1 (pt) 2022-02-22
US20140228428A1 (en) 2014-08-14
CA2845708C (en) 2019-11-12
CN111184754A (zh) 2020-05-22
AU2012307404A1 (en) 2014-03-06
AR087878A1 (es) 2014-04-23
JP6335373B2 (ja) 2018-05-30
IL231497B (en) 2019-07-31
CN103874498A (zh) 2014-06-18
WO2013037857A1 (en) 2013-03-21
ES2629186T3 (es) 2017-08-07
CA2845708A1 (en) 2013-03-21
JP2017165783A (ja) 2017-09-21
SG11201400618XA (en) 2014-05-29
SI2755669T1 (sl) 2017-06-30

Similar Documents

Publication Publication Date Title
MX2014008189A (es) Composiciones y metodos para tratar trastornos metabolicos.
MX2014014166A (es) Metodos para mejorar la seguridad del transporte de la barrera hematoencefalica.
MX2019008085A (es) Antagonistas de activina-actrii y usos para tratar transtornos oseos y otros.
UA114705C2 (uk) Андрогенна композиція для лікування офтальмологічного захворювання
CY1124473T1 (el) Φυτοσυμπλοκα απο citrus bergamia
PE20160123A1 (es) Metodos para mejorar la calidad de la composicion del meibo de las glandulas de meibomio
MX2020001835A (es) Métodos para el tratamiento de retinopatía diabética y otras enfermedades oftálmicas.
BR112015027281A8 (pt) usos de uma população de nanocarreadores sintéticos que são fixados a imunossupressores e composição compreendendo a referida população de nanocarreadores
MX2015007933A (es) Oligosacaridos de leche humana para mejorar sintomas de estres.
ECSP14017269A (es) Compuestos para tratar la atrofia muscular espinal
MX2015009104A (es) Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares.
MX2013010343A (es) Composicion y metodos para el transplante de microbiota de colon.
MX2015003228A (es) Composiciones de alcanos semifluorados.
CU24336B1 (es) Compuestos de imidazopirrolidinona
NI201400089A (es) COMPUESTOS DE OXAZOLIDIN - 2 - ONA Y USOS DE LOS MISMOS COMO INHIBIDORES DE LA PI3Ks
GT201500069A (es) Piridinonas bicìclicas novedosas
CO6710926A2 (es) Compuestos de n-heteroarilo
MX2016014509A (es) Formulacion de vitamina soluble en grasa.
MX2019009783A (es) Metodo para fabricar una barra que comprende antitranspirante.
UY35276A (es) Nuevos compuestos que inhiben la actividad de Lp-PLA2
MX2014000781A (es) Dosis combinada fija de bimatoprost y brimonidina.
GT201400288A (es) "compuestos de fenoxietil piperidina"
MX2018002446A (es) Compuestos heterociclicos fusionados como moduladores s1p.
BR112015011759A2 (pt) composição simbiótica e uso da mesma
MX2014003050A (es) Extractos de cynara scolymus para el tratamiento de la dislipidemia.

Legal Events

Date Code Title Description
FG Grant or registration